These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9782694)

  • 1. Use of alternative therapies and their impact on compliance: perceptions of community pharmacists in Texas.
    Brown CM
    J Am Pharm Assoc (Wash); 1998; 38(5):603-8. PubMed ID: 9782694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists' actions when patients use complementary and alternative therapies with medications.
    Brown CM; Barner JC; Shah S
    J Am Pharm Assoc (2003); 2005; 45(1):41-7. PubMed ID: 15730116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' actions when patients use complementary and alternative medicine with medications: A look at Texas-Mexico border cities.
    Brown CM; Pena A; Resendiz K
    J Am Pharm Assoc (2003); 2011; 51(5):619-22. PubMed ID: 21896460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
    Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
    J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of and attitudes toward resources on alternative medicine products in the community pharmacy setting.
    Nathan JP; Cicero LA; Koumis T; Rosenberg JM; Feifer S; Maltz F
    J Am Pharm Assoc (2003); 2005; 45(6):734-9. PubMed ID: 16381421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beliefs, practices and knowledge of community pharmacists regarding complementary and alternative medicine: national cross-sectional study in Lebanon.
    Hijazi MA; Shatila H; El-Lakany A; Aboul Ela M; Kharroubi S; Alameddine M; Naja F
    BMJ Open; 2019 Mar; 9(3):e025074. PubMed ID: 30852542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacists, Internet and social media: an empirical investigation.
    Shcherbakova N; Shepherd M
    Res Social Adm Pharm; 2014; 10(6):e75-e85. PubMed ID: 24388002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory study of community pharmacists' perceptions about new or transferred prescription incentives.
    Fleming M; Nemlekar P; Brown CM; Cantu R
    J Am Pharm Assoc (2003); 2012; 52(5):e53-8. PubMed ID: 23023859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' attitudes relating to patients' use of health products in Japan.
    Asahina Y; Hori S; Sawada Y
    Int J Clin Pharm; 2012 Aug; 34(4):529-37. PubMed ID: 22532015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing professional development in Texas: survey of pharmacists' knowledge and attitudes: 2008.
    Bellanger RA; Shank TC
    J Am Pharm Assoc (2003); 2010; 50(3):368-74. PubMed ID: 20452910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and interests of pharmacists regarding independent pharmacy ownership.
    Brown CM; Cantu R; Corbell Z; Roberts K
    J Am Pharm Assoc (2003); 2007; 47(2):174-80. PubMed ID: 17510004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist self-reported antidepressant medication counseling.
    Cannon-Breland ML; Westrick SC; Kavookjian J; Berger BA; Shannon DM; Lorenz RA
    J Am Pharm Assoc (2003); 2013; 53(4):390-9. PubMed ID: 23892812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Texas pharmacists' opinions about and plans for provision of medication therapy management services.
    Moczygemba LR; Barner JC; Roberson K
    J Am Pharm Assoc (2003); 2008; 48(1):38-45. PubMed ID: 18192129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    J Am Pharm Assoc (2003); 2011; 51(3):397-403. PubMed ID: 21555292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists in Australia: barriers to information provision on complementary and alternative medicines.
    Semple SJ; Hotham E; Rao D; Martin K; Smith CA; Bloustien GF
    Pharm World Sci; 2006 Dec; 28(6):366-73. PubMed ID: 17120131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of patients' and pharmacists' satisfaction with medication counseling provided by community pharmacies: a cross-sectional survey.
    Yang S; Kim D; Choi HJ; Chang MJ
    BMC Health Serv Res; 2016 Apr; 16():131. PubMed ID: 27080704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual medication management system (IMMS) implementation in pharmacists' opinion.
    Waszyk-Nowaczyk M; Lawicki S; Michalak M; Simon M
    Acta Pol Pharm; 2014; 71(3):509-14. PubMed ID: 25265831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children/young people taking long-term medication: a survey of community pharmacists' experiences in England.
    Aston J; Wilson KA; Terry DRP
    Int J Pharm Pract; 2018 Apr; 26(2):104-110. PubMed ID: 28370586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.